Form 8.3 - Dechra Pharmaceuticals plc

Societe Generale SA
06 November 2023
 

FORM 8.3

 

PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY

A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

Rule 8.3 of the Takeover Code (the "Code")

 

1.         KEY INFORMATION

 

(a) Full name of discloser:

SOCIETE GENERALE SA

(b) Owner or controller of interests and short positions disclosed, if different from 1(a):

     The naming of nominee or vehicle companies is insufficient.  For a trust, the trustee(s), settlor, and beneficiaries must be named.


(c) Name of offeror/offeree in relation to whose relevant securities this form relates:

     Use a separate form for each offeror/offeree

Dechra Pharmaceuticals plc

(d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree:


(e) Date position held/dealing undertaken:

     For an opening position disclosure, state the latest practicable date prior to the disclosure

03/11/2023

(f)  In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer?

     If it is a cash offer or possible cash offer, state "N/A"

NO

 

2.         POSITIONS OF THE PERSON MAKING THE DISCLOSURE

 

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

 

(a)        Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)

 

Class of relevant security:

 

1p ordinary

 

 

Interests

Short positions

Number

%

Number

%

(1)  Relevant securities owned and/or controlled:

6,737,618

5.92

10,002

0.01

(2)  Cash-settled derivatives:

 

0

0.00

5,088,034

4.47

(3)  Stock-settled derivatives (including options) and agreements to purchase/sell:

0

0.00

0

0.00

 

       TOTAL:

6,737,618

5.92

5,098,036

4.48

 

All interests and all short positions should be disclosed.

 

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

 

(b)        Rights to subscribe for new securities (including directors' and other employee options)

 

Class of relevant security in relation to which subscription right exists:


Details, including nature of the rights concerned and relevant percentages:


 

 

3.         DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE

 

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

 

The currency of all prices and other monetary amounts should be stated.

 

(a)        Purchases and sales

 

Class of relevant security

Purchase/sale

 

Number of securities

Price per unit

GBP

1p ordinary

Purchase

439

37.86

1p ordinary

Purchase

115

37.82

1p ordinary

Sale

877

37.86

1p ordinary

Sale

877

37.86

1p ordinary

Sale

439

37.86

1p ordinary

Sale

88

37.86

1p ordinary

Sale

877

37.86

1p ordinary

Sale

277

37.86

1p ordinary

Sale

877

37.86

1p ordinary

Sale

439

37.86

1p ordinary

Sale

162

37.86

1p ordinary

Sale

439

37.86

1p ordinary

Sale

9

37.84

1p ordinary

Sale

11

37.8

1p ordinary

Sale

28

37.8

1p ordinary

Sale

59

37.8

1p ordinary

Sale

62

37.8

1p ordinary

Sale

65

37.8

1p ordinary

Sale

80

37.8

1p ordinary

Sale

100

37.82

1p ordinary

Sale

100

37.82

1p ordinary

Sale

100

37.82

1p ordinary

Sale

118

37.82

1p ordinary

Sale

119

37.84

1p ordinary

Sale

142

37.82

1p ordinary

Sale

142

37.82

1p ordinary

Sale

163

37.84

1p ordinary

Sale

100

37.8

1p ordinary

Sale

210

37.8

1p ordinary

Sale

35

37.82

1p ordinary

Sale

36

37.82

1p ordinary

Sale

48

37.8

1p ordinary

Sale

62

37.8

1p ordinary

Sale

70

37.8

1p ordinary

Sale

100

37.82

1p ordinary

Sale

164

37.82

1p ordinary

Sale

9

37.82

1p ordinary

Sale

24

37.88

1p ordinary

Sale

50

37.82

1p ordinary

Sale

115

37.86

1p ordinary

Sale

115

37.88

1p ordinary

Sale

115

37.88

1p ordinary

Sale

115

37.9

1p ordinary

Sale

115

37.92

1p ordinary

Sale

122

37.86

1p ordinary

Sale

131

37.88

1p ordinary

Sale

155

37.8

1p ordinary

Sale

155

37.82

1p ordinary

Sale

155

37.82

1p ordinary

Sale

155

37.84

1p ordinary

Sale

155

37.86

1p ordinary

Sale

156

37.8

1p ordinary

Sale

156

37.86

1p ordinary

Sale

158

37.82

1p ordinary

Sale

165

37.86

1p ordinary

Sale

172

37.84

1p ordinary

Sale

188

37.86

1p ordinary

Sale

228

37.82

1p ordinary

Sale

240

37.82

1p ordinary

Sale

275

37.84

1p ordinary

Sale

289

37.84

1p ordinary

Sale

300

37.84

1p ordinary

Sale

500

37.84

1p ordinary

Sale

674

37.84

1p ordinary

Sale

1,200

37.84

1p ordinary

Sale

1,656

37.86

1p ordinary

Sale

1

37.86

1p ordinary

Sale

2

37.86

1p ordinary

Sale

97

37.86

1p ordinary

Sale

284

37.86

1p ordinary

Sale

407

37.86

1p ordinary

Sale

415

37.86

1p ordinary

Sale

439

37.86

1p ordinary

Sale

535

37.86

1p ordinary

Sale

751

37.86

1p ordinary

Sale

820

37.86

1p ordinary

Sale

1,262

37.86

1p ordinary

Sale

1,533

37.86

1p ordinary

Sale

2,088

37.86

1p ordinary

Sale

5,883

37.86

1p ordinary

Sale

11,617

37.86

1p ordinary

Sale

2

37.82

1p ordinary

Sale

9

37.84

1p ordinary

Sale

11

37.88

1p ordinary

Sale

12

37.84

1p ordinary

Sale

13

37.84

1p ordinary

Sale

13

37.86

1p ordinary

Sale

18

37.86

1p ordinary

Sale

19

37.84

1p ordinary

Sale

21

37.88

1p ordinary

Sale

50

37.88

1p ordinary

Sale

51

37.88

1p ordinary

Sale

53

37.88

1p ordinary

Sale

58

37.88

1p ordinary

Sale

63

37.88

1p ordinary

Sale

71

37.88

1p ordinary

Sale

77

37.86

1p ordinary

Sale

85

37.84

1p ordinary

Sale

99

37.88

1p ordinary

Sale

100

37.84

1p ordinary

Sale

103

37.82

1p ordinary

Sale

104

37.84

1p ordinary

Sale

105

37.88

1p ordinary

Sale

106

37.86

1p ordinary

Sale

108

37.82

1p ordinary

Sale

108

37.82

1p ordinary

Sale

108

37.86

1p ordinary

Sale

109

37.88

1p ordinary

Sale

109

37.88

1p ordinary

Sale

109

37.88

1p ordinary

Sale

111

37.82

1p ordinary

Sale

114

37.92

1p ordinary

Sale

115

37.88

1p ordinary

Sale

115

37.9

1p ordinary

Sale

116

37.82

1p ordinary

Sale

123

37.86

1p ordinary

Sale

123

37.86

1p ordinary

Sale

137

37.88

1p ordinary

Sale

170

37.88

1p ordinary

Sale

271

37.88

 

(b)        Cash-settled derivative transactions

 

Class of relevant security

Product description

e.g. CFD

Nature of dealing

e.g. opening/closing a long/short position, increasing/reducing a long/short position

Number of reference securities

Price per unit

GBP

 

(c)        Stock-settled derivative transactions (including options)

 

(i)         Writing, selling, purchasing or varying

 

Class of relevant security

Product description e.g. call option

Writing, purchasing, selling, varying etc.

Number of securities to which option relates

Exercise price per unit

Type

e.g. American, European etc.

Expiry date

Option money paid/ received per unit

 

(ii)        Exercise

 

Class of relevant security

Product description

e.g. call option

Exercising/ exercised against

Number of securities

Exercise price per unit

 

(d)        Other dealings (including subscribing for new securities)

 

Class of relevant security

Nature of dealing

e.g. subscription, conversion

Details

Price per unit (if applicable)

 

 

4.         OTHER INFORMATION

 

(a)        Indemnity and other dealing arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

Irrevocable commitments and letters of intent should not be included.  If there are no such agreements, arrangements or understandings, state "none"

 

None

 

(b)        Agreements, arrangements or understandings relating to options or derivatives

 

Details of any agreement, arrangement or understanding, formal or informal, between the person making the disclosure and any other person relating to:

(i)  the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

None

 

(c)        Attachments

 

Is a Supplemental Form 8 (Open Positions) attached?

NO

 

 

Date of disclosure:

06/11/2023

Contact name:

Paul Jenkins

Telephone number:

+44 20 7676 6969

 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.

 

The Panel's Market Surveillance Unit is available for consultation in relation to the Code's disclosure requirements on +44 (0)20 7638 0129.

 

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UK 100

Latest directors dealings